Dr. Lin Dongmei
林冬梅
Chief Physician; Professor; Doctoral Supervisor; Director of Pathology Department
Where they practice, who they consult.
- Peking University Cancer Hospital & Institute, Beijing
- 25+ years in surgical and molecular pathology
- English, Mandarin
What they personally lead.
Training and recognition
Led standardization of HER2 IHC and ISH testing in gastric cancer in China; co-author of national gastric cancer pathology consensus documents; Peking University Cancer Hospital pathology is one of the top GI tumor diagnostic centers in northern China
What to expect
Strong choice for gastric and esophageal cancer cases requiring HER2 status confirmation before trastuzumab or trastuzumab deruxtecan therapy.
Check the public record
Look up publications, citations, and academic profile on independent platforms before reaching out.
Results are automated searches and may include other individuals with similar names.
Ask the AI or request a coordinator.
The AI can compare Lin Dongmei's background to other specialists in Beijing. A coordinator can confirm appointment availability and English-language support.
Information is provided for reference only and may not reflect current conditions. Verify directly with the hospital before making decisions.